BRCA1 and ovarian cancer: In the NCIC study which correlated BRCA1 protein expression by ICH with corresponding clinical data, 251 ovarian cancer samples were analyzed using a mouse monoclonal BRCA1 antibody (MS110, Calbiochem, Germany) and 65% of the tumors showed no staining or very mild staining [29].